Synthesis and Antiviral Study of Cyclopentano [d] Pyrimidine-2,4-diones and Octahydroquinazoline-2,4-diones Acyclic Nucleosides as Potential Anti-HIV Agents
摘要:
The Vorbruggen and Niedballa's method((1)) afforded new cycropentano [d] pyrimidine-2,4-dione and octahydroquinazoline-2,4-dione nucleosides. Various modifications of these new derivatives enabled us to obtain HEPT related compounds which were tested against Human Immunodeficiency Virus-1 (HIV-1). Unfortunately, none of these compounds showed significant antiviral activity.
Synthesis and Antiviral Study of Cyclopentano [d] Pyrimidine-2,4-diones and Octahydroquinazoline-2,4-diones Acyclic Nucleosides as Potential Anti-HIV Agents
摘要:
The Vorbruggen and Niedballa's method((1)) afforded new cycropentano [d] pyrimidine-2,4-dione and octahydroquinazoline-2,4-dione nucleosides. Various modifications of these new derivatives enabled us to obtain HEPT related compounds which were tested against Human Immunodeficiency Virus-1 (HIV-1). Unfortunately, none of these compounds showed significant antiviral activity.
The present invention relates to the use of certain 4-substituted pyrimidine derivatives as mGluR1 antagonists, to novel 4-substituted pyrimidine derivatives, to pharmaceutical formulations comprising 4-substituted pyrimidine derivatives, to a process for preparing 4-substituted pyrimidine derivatives and to intermediates useful in the preparation of 4-substituted pyrimidine derivatives.
Synthesis and Antiviral Study of Cyclopentano [<i>d</i>] Pyrimidine-2,4-diones and Octahydroquinazoline-2,4-diones Acyclic Nucleosides as Potential Anti-HIV Agents
作者:J. Renault、D. Laduree、M. Robba
DOI:10.1080/15257779408011863
日期:1994.5
The Vorbruggen and Niedballa's method((1)) afforded new cycropentano [d] pyrimidine-2,4-dione and octahydroquinazoline-2,4-dione nucleosides. Various modifications of these new derivatives enabled us to obtain HEPT related compounds which were tested against Human Immunodeficiency Virus-1 (HIV-1). Unfortunately, none of these compounds showed significant antiviral activity.